Trial Profile
Longitudinal chemodenervation effects of botulinum toxin A after intramuscular application and the impact of physical activity
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Acronyms BoNT- physical activity and chemodenervation
- 01 Mar 2021 This trial has been completed in Austria (Global end date: 1 Feb 2021).
- 08 Jun 2018 New trial record